Latest News about ALZN
Recent news which mentions ALZN
Hewlett Packard Enterprise To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Thursday
August 21, 2025
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Nasdaq Gains Over 1%; Nvidia Posts Strong Revenue
May 29, 2025
From Benzinga
From Benzinga
EXCLUSIVE: Alzamend Neuro Initiates First Phase 2 Trial Of Lead Program In Healthy Human Participants
May 13, 2025
From Benzinga
EXCLUSIVE: Alzamend Neuro Partners with QMENTA To Advance AI-Powered Imaging For Is Phase 2 Trial Of Lead Program
May 07, 2025
From Benzinga
EXCLUSIVE: Alzamend Neuro To Launch Phase 2 Study For Lead Drug For PTSD Patients In Late 2025 To Assess Lithium Delivery Benefits
March 11, 2025
From Benzinga
From Benzinga
EXCLUSIVE: Alzamend Neuro Says Tesla Dynamic Completes Head Coil To Measure Brain Structure Lithium Levels
February 19, 2025
From Benzinga
EXCLUSIVE: Alzamend Neuro Reveals Full Data From Nonclinical Study Of Its Lead Alzheimer's Drug Potential
November 19, 2024
From Benzinga
EXCLUSIVE: Alzamend Neuro Reveals Full Data Set From Multiple Ascending Dose Trial For Lead Candidate For Dementia Related to Alzheimer's
October 16, 2024
From Benzinga
Why Bit Digital Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
August 20, 2024
From Benzinga
Nvidia, AMD, Alzamend Neuro, Palo Alto Networks, Tesla: Why These 5 Stocks Are On Investors' Radars Today
August 19, 2024
From Benzinga
Nasdaq Surges 150 Points; Sonder Holdings Shares Surge
August 19, 2024
From Benzinga
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 19, 2024
From Benzinga
Crude Oil Down 2%; Alzamend Neuro Shares Spike Higher
August 19, 2024
From Benzinga
From Benzinga
From Benzinga
EXCLUSIVE: Alzamend Neuro To Assess AL001 Alzheimer's Candidate Against Commonly Marketed Lithium Salt In Phase 2 Head-To-Head Study
August 05, 2024
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
EXCLUSIVE: Alzamend Neuro To Raise Up To $25M Via Private Placement Of Preferred Shares
May 09, 2024
From Benzinga
From Benzinga
Alzamend Neuro Halts Equity Offering Program, Prioritizing Shareholder Value Amid Strategic Shift, Shares Slide
May 07, 2024
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.